Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels |
---|---|---|---|
1 | |||
Hypersensitivity | postmarketing | x | |
Hypotension | postmarketing | x | |
Shock | postmarketing | x | |
Sepsis | postmarketing | x | |
Anaemia | x | ||
Clotting | x | ||
Coagulopathy | x | ||
Pancreatitis | x | ||
Pruritus | x | ||
Prothrombin level increased | x | ||
Wound haemorrhage | x | ||
Anaphylactoid reaction | x | ||
Serum amylase increased | x | ||
Haematocrit decreased | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | ||
---|---|---|---|
Hypovolaemia | x | ||
Sepsis | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |